Joan Cox Gill, MD

Titles
Program director, Hemophilia, Children's Hospital of Wisconsin; director, Comprehensive Center for Bleeding Disorders, BloodCenter of Wisconsin; professor, Pediatrics and Medicine, Medical College of Wisconsin.

Division
Hematology, Oncology and Transplant

Research interests
Bleeding and blood disorders

Study interests
Hemophilia, hemophilic inhibitors, hepatitis C, HIV, thrombosis, von Willebrand disease.

Education
Medical degree, Medical College of Wisconsin, Milwaukee, 1976; residency, Medical College of Wisconsin and Children's Hospital of Wisconsin, Milwaukee, 1978; fellowship, Medical College of Wisconsin, Children's Hospital of Wisconsin and The Blood Center, Milwaukee, 1981.

Certifications
American Board of Pediatric Hematology/Oncology, American Board of Pediatrics.

Honors
1992 visiting professor, Columbus Children's Hospital, Columbus, Ohio; 1995 visiting professor, Mayo Clinic, Rochester, Minn.; visiting professor, University Medical Center, Jackson, Miss.; Best Doctors in America, 1996-present.

Representative publications

• Gill JC, Endres‑Brooks J, Bauer PJ, Marks WJ, Montgomery RR. The Effect of ABO Blood Group on the Diagnosis of Von Willebrand Disease. Blood. 1987; 69: 1691‑96.
• Eckels DD, Tabatabai N, Bian TH, Wang H, Muheisen SS, Rice CM, Yoshizawa K, Gill JC. In Vitro Human T-Cell Responses to a Recombinant Hepatitis C Virus Antigen: Failure in IL-2 Production Despite Proliferation. Human Immunolology. 1999; 60:187-199.
• Gill JC. The Role of Genetics in Inhibitor Formation. Thrombosis Haemostasis. 1999; 82:500-505.
• Punzalan RC, Hillery CA, Montgomery RR, Scott JP, Gill JC. Low Molecular Weight Heparin (Enoxaparin) in Thrombotic Disease in Children and Adolescents. American Journal of Pediatric Hematology Oncology. 2000; 22:137-142.
• Gill JC, Ottum M, Schwartz B. Evaluation of High Concentration Intranasal and Intravenous Desmopressin in Pediatric Patients with Mild Hemophilia A or Mild-to-Moderate Type 1 von Willebrand Disease. Journal of Pediatrics. 2002; 140:595-599.
• Gill JC. Diagnosis and Treatment of von Willebrand Disease. Hematology/Oncology Clinics of North America. 2004; 18:1277-1299.

Grants

• Region V-West Hemophilia Treatment Center Network, Director of Regional Center, The Comprehensive Center for Bleeding Disorders, 10/01/96-9/30/05.
• Prevention of the Complications of Hemophilia through Hemophilia Treatment Centers, Director of Regional Center, The Comprehensive Center for Bleeding Disorders, 10/01/96-9/30/05.

Contact
Children's Hospital of Wisconsin
PO Box 1997
Milwaukee, WI 53201
Phone: (414) 257-2424
Fax: (414) 937-6580
E-mail: coxgillj@mcw.edu